Randomized Controlled Trial of Annual Zoledronic Acid to Prevent Gonadotropin-Releasing Hormone Agonist–Induced Bone Loss in Men With Prostate Cancer We identified 210 patients from 1989 to 2003 with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results